Benitec Biopharma Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for BNTC, updated each market day.
BNTC AI Sentiment
AI predicts Benitec Biopharma Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Benitec Biopharma Inc. Common Stock
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
Sector
Exchange
Market Cap
$378,241,217
Cap Tier
Employees
19
Headquarters
HAYWARD, CA
Listed Since
July 11, 2012
Website
BNTC Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
BNTC Volatility
Benitec Biopharma Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
